Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways
about
Reduction of atherosclerosis in mice by inhibition of CD40 signallingImmunological aspects of liver cell transplantationTolerogenic Dendritic Cells on Transplantation: Immunotherapy Based on Second Signal BlockagePluripotent stem cells: immune to the immune system?Biologics in organ transplantationTransplantation tolerance and its outcome during infections and inflammationFuture prospects in immunosuppression for liver transplantationRegulatory T-cells: diverse phenotypes integral to immune homeostasis and suppressionA novel monoclonal antibody to CD40 prolongs islet allograft survivalDefinition of agonists and design of antagonists for alloreactive T cell clones using synthetic peptide libraries.Co-stimulation blockade targeting CD154 and CD28/B7 modulates the induced antibody response after a pig-to-baboon cardiac xenograft.Blockade of CD28 by a synthetical peptoid inhibits T-cell proliferation and attenuates graft-versus-host diseasePathogen Stimulation History Impacts Donor-Specific CD8(+) T Cell Susceptibility to Costimulation/Integrin Blockade-Based TherapyTransplantation tolerance: the concept and its applicability.Gene therapy in transplantation.The problem of anti-pig antibodies in pig-to-primate xenografting: current and novel methods of depletion and/or suppression of production of anti-pig antibodies.Transplantation tolerance-where do we stand?Blocking costimulatory signals to induce transplantation tolerance and prevent autoimmune disease.Antigen presentation by parenchymal cells: a route to peripheral tolerance?Tissue engineering: confronting the transplantation crisis.CD28, CTLA-4 and their ligands: who does what and to whom?CTLA4-Ig: a novel immunosuppressive agent.Promoting long-term survival of insulin-producing cell grafts that differentiate from adipose tissue-derived stem cells to cure type 1 diabetesNew-generation recombinant factor concentrates: bridge to gene therapy.Current treatment practice in immunosuppression.Multiple costimulatory blockade in the peripheral nerve allograft.Immunosuppression without immunosuppression? How to be a tolerant individual in a dangerous world.Selective immunointervention in autoimmune diseases: lessons from multiple sclerosis.Belatacept and sirolimus prolong nonhuman primate renal allograft survival without a requirement for memory T cell depletion.CD154 blockade alters innate immune cell recruitment and programs alloreactive CD8+ T cells into KLRG-1(high) short-lived effector T cells.Renal transplantation using belatacept without maintenance steroids or calcineurin inhibitors.A model of corrective gene transfer in X-linked ichthyosis.CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primatesTransient lymphopenia breaks costimulatory blockade-based peripheral tolerance and initiates cardiac allograft rejectionIslet cell transplantation for the treatment of diabetes mellitus.Requirement for natural killer T (NKT) cells in the induction of allograft toleranceNuclear calcium is required for human T cell activation.Multipotent mesenchymal stromal cells synergize with costimulation blockade in the inhibition of immune responses and the induction of Foxp3+ regulatory T cells.New approaches to immunosuppression in liver transplantation.Costimulation blockade inhibits the indirect pathway of allorecognition in nerve allograft rejection
P2860
Q24316540-2755F5D0-B7FE-4C1A-A061-3DD3F26A09C4Q26751474-D9D45B90-63B9-4F18-8FD5-C6B3D1056F2BQ26778646-798F5789-874C-44A7-882A-DAEF375AEACFQ26823255-31868209-C904-45F5-B0B2-3445B284311CQ26829578-E1107729-9C6D-48A7-ABAD-303A3AE6188FQ26829817-29CEB236-19D7-4D0B-B0F2-938E56A3BD33Q26860486-35431C5B-877E-4955-9162-056D2C1F2200Q27022973-8BC624BE-0145-47F3-9110-B4A5107A49A7Q30417821-F44B3D88-79AE-4AB3-BF76-BEBCC18CC986Q30698407-4FC9C831-277C-4BC8-B5BA-4FB371AE614AQ33365683-693BCE3C-B5A1-479E-8E54-9B6F89C75F28Q33530054-544B295A-B016-4751-8293-3EAC070D51E6Q33636211-2D44146B-ACEA-425E-898E-96347FB93495Q33732945-947CF882-7FC7-48DF-BF2E-532B5F7F8DCAQ33734501-21444C82-FF39-4FBB-8264-B8E9A1628CEBQ33742186-E88C0418-6505-453B-AFE1-AD50D8E2FFE4Q33764678-AEDD4405-F01C-4E74-975B-ACE56D682174Q33805849-FC06884E-0CC4-471D-B06B-F78F426F783DQ33815462-93AF2373-0291-4897-8C8C-CCA6A94FB087Q33863367-B7BEBC1E-17F2-47BD-972C-10E040CD4242Q34049974-6AAE9E07-F46D-4739-9070-9557915DCF8EQ34075083-D2DDA74B-019C-41F0-A45C-3D044F8D1059Q34117889-B8158E58-15F7-4DA2-BF02-D533B0FFA348Q34176033-0A179435-9007-4A43-8FCB-2E7AA3DE3924Q34181796-A9C81C7D-B44C-414D-A527-0395D4B2E969Q34246339-6A2B1386-F535-49AB-B180-4362C0BE9E78Q34294802-319B7E0B-ECEE-4843-93CE-B76C0093B37AQ34307160-D6906744-F0EC-4FD6-8848-9E404A1E5D15Q34322116-D19B700F-8E12-4ADE-B1A8-E377FF2395CCQ34336527-64CF8342-74AD-42F7-9A94-74AFF946C8E6Q34412887-2FEEC5C2-F9CF-4517-9C3F-0F18BAD3161BQ34428074-1ADD02A1-B5BF-44D7-95D3-56E6C96E80CDQ34433847-917E21DD-5725-4A48-97E3-3254D4606BEDQ34438306-70BAAA4A-897D-405B-9EA9-80905C301C99Q34452096-2BB713F4-03B0-49C6-8C46-846B20B38B4BQ34475968-D826E65F-E22A-4A73-8DB4-7720CFAFE37BQ34544029-44D9DFB7-F03A-476F-B0FC-5D8BD02F37FEQ34601883-DF10CA77-48BE-4AB4-B916-7F2D10825689Q34609660-B2FA9CCC-15FB-431B-8600-2887CCBE1F1AQ34675132-7337F257-D9C6-4BE6-BE7C-A6806DB233AF
P2860
Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways
description
article publié dans la revue scientifique Nature
@fr
наукова стаття, опублікована в травні 1996
@uk
name
Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways
@en
type
label
Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways
@en
prefLabel
Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways
@en
P2093
P356
P1433
P1476
Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways
@en
P2093
Alejandro Aruffo
Carol Tucker-Burden
Christian P. Larsen
Diane Hollenbaugh
Diane Z. Alexander
Eric T. Elwood
Hong Rae Cho
Kevin J. Winn
Peter S. Linsley
Rose Hendrix
P2888
P304
P356
10.1038/381434A0
P407
P577
1996-05-01T00:00:00Z
P6179
1027764557